glp-1 and multiple sclerosis drug enters trial for progressive GLP-1 Agonists in Cardiovascular Diseases:

This innovation will increase the therapeutic potential of mAbs in CVD, where multiple signaling pathways need to be modulated

Johnson, MD, Chief Medical Director of CenExel Metabolic and Principal Investigator, and Margot Witteveen, MS, RDN, LD, Research Registered Dietitian Nutritionist at CenExel Decatur, highlight why monitoring nutritional adequacy is critical in metabolic studies

Dioxygenase JID1 mediates the modification of OPDA to regulate jasmonate homeostasis

These 23 Probiotics Actually Help The GAIA Study explains nutrition is becoming a frontline tool in holistic healing for Gen Z and Millennials When You Miss a Dose, Your Appetite Fights Back GLP-1s work by mimicking the hormones that tell you youre full

These insights provide a framework for precision medicine, where genetic profiling may help refine risk stratification and guide targeted therapeutic strategies

Eligibility to File a GLP-1 Lawsuit in Kentucky You may qualify for a GLP-1 lawsuit if you were prescribed a GLP-1 drug and suffered serious health complications as a result